Japan, Nov. 12 -- INCYTE CORP has got intellectual property rights for 'COMBINATION OF RUXOLITINIB AND INCB057643 FOR TREATING MYELOPROLIFERATIVE NEOPLASM.' Other related details are as follows:
Application Number: JP,2025-067272
Category (FI): A61P35/00,A61K31/519,A61K31/538,A61P35/02,A61P43/00,121
Stage: Grant (IP right granted following substantive examination.)
Filing Date: April 16, 2025
Publication Date: July 30, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....